Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

43 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Effect of early addition of rosiglitazone to sulphonylurea therapy in older type 2 diabetes patients (>60 years): the Rosiglitazone Early vs. SULphonylurea Titration (RESULT) study.
Rosenstock J, Goldstein BJ, Vinik AI, O'neill MC, Porter LE, Heise MA, Kravitz B, Dirani RG, Freed MI; RESULT Study Group. Rosenstock J, et al. Among authors: freed mi. Diabetes Obes Metab. 2006 Jan;8(1):49-57. doi: 10.1111/j.1463-1326.2005.00541.x. Diabetes Obes Metab. 2006. PMID: 16367882 Clinical Trial.
Rosiglitazone monotherapy is effective in patients with type 2 diabetes.
Lebovitz HE, Dole JF, Patwardhan R, Rappaport EB, Freed MI; Rosiglitazone Clinical Trials Study Group. Lebovitz HE, et al. Among authors: freed mi. J Clin Endocrinol Metab. 2001 Jan;86(1):280-8. doi: 10.1210/jcem.86.1.7157. J Clin Endocrinol Metab. 2001. PMID: 11232013 Clinical Trial.
43 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page